Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
Posts by this author
London – On Tuesday, (12th May) CTS Virtual (https://arena-international.com/ctsvirtual/), will host new key sessions on Clinical Trial Supply 2020 Trends, Stem-gene Clinical Trials and many more.
As modern medicine advances, the global clinical supply chain needs to keep up, and the expanding market for stem-cell and gene therapy is making this increasingly complex for companies doing research and development in these areas. The therapeutic potential for stem-cell and gene products is vast, with targeted personalized medicine to suit the individual needs of sick patients, but running clinical supply operations in these fields can come at a high cost and requires detailed planning.